154 related articles for article (PubMed ID: 27667671)
1. Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol.
Emmi G; Silvestri E; Cantarini L; Lopalco G; Cecchi L; Chiarini F; Farsi A
J Dermatol; 2017 Aug; 44(8):981-982. PubMed ID: 27667671
[No Abstract] [Full Text] [Related]
2. Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction.
YIlmaz I; Türk M; Nazik Bahçecioğlu S
Eur Ann Allergy Clin Immunol; 2018 Mar; 50(2):94-96. PubMed ID: 29384104
[TBL] [Abstract][Full Text] [Related]
3. Successful desensitization with anakinra in a case with immediate hypersensitivity reaction.
Şoyyiğit S; Kendirlinan R; Aydın O; Çelik GE
Ann Allergy Asthma Immunol; 2014 Sep; 113(3):325-6. PubMed ID: 25065572
[No Abstract] [Full Text] [Related]
4. Successful rapid subcutaneous desensitization to anakinra in a case of delayed-type hypersensitivity reaction.
Leroy V; Lazaro E; Darrigade AS; Taïeb A; Milpied B; Seneschal J
Br J Dermatol; 2016 Jun; 174(6):1417-8. PubMed ID: 26852184
[No Abstract] [Full Text] [Related]
5. Rapid Desensitization to Adalimumab Is Associated With Decreased Basophil Sensitivity.
Thévenot J; Ferrier le Bouëdec MC; Buisson A; Bommelaer G; D'Incan M; Rouzaire P
J Investig Allergol Clin Immunol; 2019 Apr; 29(2):141-143. PubMed ID: 31017114
[No Abstract] [Full Text] [Related]
6. Adalimumab desensitization protocol in a patient with a generalized urticarial reaction and angioedema following adalimumab administration.
Gutiérrez Fernández D; Foncubierta Fernández A; Anguita Carazo JL; Fernández Meléndez S; Fernández Anguita MJ; Medina Varo F
J Investig Allergol Clin Immunol; 2014; 24(4):273-5. PubMed ID: 25219112
[No Abstract] [Full Text] [Related]
7. Rapid subcutaneous desensitization for the management of local and systemic hypersensitivity reactions to etanercept and adalimumab in 12 patients.
Bavbek S; Ataman Ş; Akıncı A; Castells M
J Allergy Clin Immunol Pract; 2015; 3(4):629-32. PubMed ID: 25725941
[No Abstract] [Full Text] [Related]
8. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
[No Abstract] [Full Text] [Related]
9. Desensitization to hydroxychloroquine: alternative interpretations.
Sontheimer RD
J Rheumatol; 2007 Feb; 34(2):253-5; discussion 255. PubMed ID: 17304648
[No Abstract] [Full Text] [Related]
10. New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra.
González-López MA; Martínez-Taboada VM; González-Vela MC; Fernández-Llaca H; Val-Bernal JF
Br J Dermatol; 2008 May; 158(5):1146-8. PubMed ID: 18284383
[No Abstract] [Full Text] [Related]
11. Interstitial granulomatous drug reaction to anakinra.
Regula CG; Hennessy J; Clarke LE; Adams DR; Ioffreda MD; Graber EM; Helm KF
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S25-7. PubMed ID: 18625373
[TBL] [Abstract][Full Text] [Related]
12. Anakinra delayed skin allergy expressing as both injection site reactions and generalized exanthema.
Lungoci ER; Hacard F; Nicolas JF; Berard F
Eur J Dermatol; 2015; 25(5):503-4. PubMed ID: 26575828
[No Abstract] [Full Text] [Related]
13. Hypersensitivity reaction to darunavir and desensitization protocol.
Marcos Bravo MC; Ocampo Hermida A; Martínez Vilela J; Pérez Rodríguez MT; Gavilán Montenegro MJ; Arenas Villarroel LJ; Miralles Alvarez C; Rodríguez Dasilva A; Martínez Vázquez C
J Investig Allergol Clin Immunol; 2009; 19(3):250-1. PubMed ID: 19610279
[No Abstract] [Full Text] [Related]
14. Anakinra for the treatment of rheumatoid arthritis: a safety evaluation.
Ramírez J; Cañete JD
Expert Opin Drug Saf; 2018 Jul; 17(7):727-732. PubMed ID: 29883212
[TBL] [Abstract][Full Text] [Related]
15. Successful Desensitization Protocol for Hypersensitivity Reaction Caused by Irinotecan in a Patient With Metastatic Colorectal Cancer.
Abu-Amna M; Hassoun G; Hadad S; Haim N; Bar-Sela G
Clin Colorectal Cancer; 2015 Dec; 14(4):e49-51. PubMed ID: 26051444
[No Abstract] [Full Text] [Related]
16. An effusion of blood and phlegmon secondary to anakinra injection.
Ortiz AE; Fulwider CM; Wu JJ
Cutis; 2010 Mar; 85(3):130-1. PubMed ID: 20408510
[No Abstract] [Full Text] [Related]
17. Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.
Ruiz PJ; Masliah E; Doherty TA; Quach A; Firestein GS
Ann Rheum Dis; 2007 Mar; 66(3):422-3. PubMed ID: 17179171
[No Abstract] [Full Text] [Related]
18. Desensitization to hydroxychloroquine: 4 cases.
Caramaschi P; Barbazza R; Tinazzi I; Biasi D
J Rheumatol; 2011 Oct; 38(10):2267; author reply 2267. PubMed ID: 21965696
[No Abstract] [Full Text] [Related]
19. Subacute liver failure following anakinra treatment for adult-onset Still disease.
Aly L; Iking-Konert C; Quaas A; Benten D
J Rheumatol; 2013 Oct; 40(10):1775-7. PubMed ID: 24085761
[No Abstract] [Full Text] [Related]
20. Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: drug reintroduction can be successful.
Perrin F; Néel A; Graveleau J; Ruellan AL; Masseau A; Hamidou M
Presse Med; 2014 Mar; 43(3):319-21. PubMed ID: 24456697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
